The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate change

22 Mar 2022 07:00

RNS Number : 5236F
Cellular Goods PLC
22 March 2022
 

Press release

 

22 March 2022

 

Cellular Goods PLC

 

('Cellular Goods' or 'the Company')

 

Directorate change

 

Senior operational management strengthened

 

Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-made cannabinoids, is pleased to announce a reorganisation of its executive management team to support the next stage of the Company's growth.

 

Eric Chang, Chief Operating Officer and a Director of Cellular Goods, is stepping down from the board and leaving the Company on the 15th of April 2022. The Company will not appoint another Chief Operating Officer.

 

A new position of Chief Supply Chain Officer is being created to strengthen the operational management team, improve efficiency in delivering the Company's strategy and reduce its cost base. Nikhil Vijayan has been appointed as the Chief Supply Chain Officer, effective from 28 March 2022. Nikhil will be based in London, providing a talent upgrade to the Company's UK operations.

 

Nikhil has a track record of more than 14 years in supply chain management with high-level industry experience at leading consumer goods organisations including Procter & Gamble ("P&G") and professional services leader Deloitte.

 

While at P&G, Nikhil's responsibilities included leading end-to-end supply chain operations for a number of products in the company's baby care, feminine care, pet care and healthcare ranges, and successfully directing a team of planners to develop production strategies for the company's sizeable fabric conditioner product portfolio across three manufacturing sites in Europe. In his role at Deloitte, he focused on supporting consumer clients with the design and delivery of large-scale supply chain transformations.

 

Eric, who is based in Vancouver, and has served as Chief Operating Officer since February 2021, was part of the team that oversaw Cellular Goods' listing on the London Stock Exchange and the successful launch of the Company's inaugural 'Look Better' (skincare) and 'Feel Better' (supplements) product ranges in December 2021.

 

Anna Chokina, Chief Executive Officer, commented: "On behalf of Cellular Goods, I would like to thank Eric for his excellent work and wish him well in all his future endeavours. Eric worked tirelessly to bring Cellular Goods to the London Stock Exchange and to support the launch of our inaugural product ranges.

 

"I am delighted to welcome Nikhil, who will strengthen our operational management capabilities and enhance the Company's delivery of new products. His appointment as Chief Supply Chain Officer is a great step towards achieving our growth plans. He brings a wealth of experience in developing and managing supply chains for global consumer brands. His expertise will not only ensure that we can continue delivering high-quality products to our customers, but it will also be key to the successful launch of new products this year and beyond."

 

 

For further information please contact:

Cellular Goods

Anna Chokina

Chief Executive

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

Tennyson Securities

Corporate Broker

Peter Krens

 

+44 207 186 9030

Novum Securities

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

Tancredi Intelligent Communication

Media Relations

Helen Humphrey

Gabriela Amaya Garcia

Edward Daly

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 791 503 5294

+44 786 143 0057

+44 789 755 7112

 

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBGDXDXDDGDB
Date   Source Headline
23rd Dec 20227:00 amRNSTR-1: Standard notification of major holdings
23rd Dec 20227:00 amRNSCellular Goods Annual Results
23rd Nov 20226:16 pmRNSTR-1: Standard notification of major holdings
2nd Nov 202210:34 amRNSTR-1: Standard notification of major holdings
24th Oct 20227:00 amRNSProducts launch on Debenhams.com
20th Oct 20227:00 amRNSLaunch of gift set collection for festive season
26th Sep 20227:00 amRNSProposed purchase of Cannaray Brands and Love CBD
23rd Sep 20225:49 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:47 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:42 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
21st Sep 20222:06 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSLaunch of three new skincare products
6th Sep 20227:00 amRNSPublication of new white paper
17th Aug 20227:00 amRNSGrant of Share Options
16th Aug 20227:00 amRNSAppointment of new Chief Financial Officer
5th Aug 20224:40 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
4th Aug 20229:05 amRNSSecond Price Monitoring Extn
4th Aug 20229:00 amRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20229:05 amRNSSecond Price Monitoring Extn
3rd Aug 20229:00 amRNSPrice Monitoring Extension
2nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
2nd Aug 202211:05 amRNSSecond Price Monitoring Extn
2nd Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20222:00 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSUpdate on marketing initiatives and YouGov survey
11th Jul 20227:00 amRNSLaunch of minis
20th Jun 20227:00 amRNSLaunch of CBG and CBD petition
30th May 20227:00 amRNSInterim results
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
16th May 20222:05 pmRNSSecond Price Monitoring Extn
16th May 20222:00 pmRNSPrice Monitoring Extension
12th May 20227:00 amRNSBoard changes
28th Apr 20227:00 amRNSInvestor presentation
28th Apr 20227:00 amRNSFirst patent application filed
22nd Apr 20226:04 pmRNSUpdate on ingestibles product range
22nd Apr 20227:00 amRNSWhite paper on lab-produced cannabinoids
13th Apr 20227:00 amRNSUpdate on ingestibles product range
11th Apr 20227:00 amRNSUpdate on ingestibles products
7th Apr 202210:24 amRNSTR-1: Standard notification of major holdings
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
28th Mar 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.